Reported 5 months ago
As human cases of bird flu rise, retail traders are investing in vaccine stocks like CureVac NV, Novavax Inc., Moderna Inc., and Pfizer Inc. to capitalize on the potential outbreak. This trend of trading frenzy during disease outbreaks is not new, with past outbreaks like Ebola and Zika causing similar market fluctuations. However, experts caution that it's uncertain if the bird flu will have a significant impact on revenue, advising traders to sell into the strength of the current market reactions.
Source: YAHOO